Product/Composition:- | Eltrombopag |
---|---|
Strength:- | Tablet: 12.5 mg, 25 mg, 50 mg, 75 mg; Suspension:25 mg per packet |
Form:- | Oral Tablets & Oral Powder for Oral Suspension |
Reference Brands:- | Promacta,Revolade |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Eltrombopag is an oral thrombopoietin receptor agonist used to treat chronic ITP, severe aplastic anemia, and hepatitis C-related thrombocytopenia. Marketed as Promacta and Revolade, it boosts platelet production and reduces transfusion needs. Ideal for pharma B2B sourcing.
Eltrombopag is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and hepatitis C-associated thrombocytopenia. Marketed globally as Promacta (US) and Revolade (EU/Worldwide), it stimulates platelet production and reduces bleeding risk. Available in GMP-certified oral tablets and pediatric suspension, Eltrombopag is a high-demand product in hematology. Ideal for pharmaceutical wholesalers, importers, and B2B buyers seeking reliable sourcing of specialty medicines. We offer bulk supply, export support, and regulatory documentation. Partner with us for competitive pricing and global delivery of Eltrombopag. Contact us today to secure your supply of Eltrombopag for pharma B2B needs.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications